Legal Disclosures
Last updated: 24 April 2026
Affiliate disclosure (DSA Article 26)
Under the EU Digital Services Act (DSA, Regulation 2022/2065), Article 26, platforms must disclose when content is a commercial communication. EU Peptide Guide earns commissions from certain — but not all — outbound vendor links on this site. Where we earn commission, the outbound link carries rel="sponsored". A visible research-use-and-affiliate disclosure appears on every page that contains such a link.
Affiliate partnerships as of April 2026 are disclosed in full on our About page. Commission receipt does not alter editorial ranking or scoring. For the scoring methodology, see our methodology page.
Research-use-only framing
All peptides discussed on this site are sold strictly for scientific research purposes and are not approved for human therapeutic use in any EU jurisdiction. Content on this site does not constitute medical advice and does not encourage, direct, or imply any human administration of the compounds discussed.
This framing is required under EU Directive 2001/83/EC Title VIII (advertising of medicinal products) and its national transpositions. Any reader considering use of a research compound must comply with applicable institutional ethics, biosafety, and regulatory requirements in their jurisdiction.
Per-country regulatory posture
The research-use-only legal frame does not mean identical enforcement across EU member states. Enforcement posture as of April 2026:
| Jurisdiction | Primary regulator | Enforcement |
|---|---|---|
| Germany, Austria | BfArM (DE); AGES (AT) | Strictest — HWG (Heilmittelwerbegesetz) is the tightest EU transposition |
| Switzerland | Swissmedic | Strict — non-EU regime; separate customs |
| France | ANSM + DGCCRF | Moderate-strict — therapeutic claims trigger action |
| Italy | AIFA | Moderate — D.lgs. 219/2006 transposition |
| Spain | AEMPS | Moderate |
| Netherlands, Belgium | CBG-MEB (NL); FAMHP (BE) | Moderate |
| Nordic (SE, NO, DK, FI) | Läkemedelsverket / Statens Legemiddelverk / Lægemiddelstyrelsen / Fimea | Moderate |
| Other EU (PL, CZ, SK, HU, RO, HR, SI, BG, LT, LV, EE) | National agencies | Historically lighter enforcement — RUO framing still required |
Buyers are responsible for compliance in their own jurisdiction. Sanctions enforcement (Russia) and post-Brexit customs (UK) introduce additional complications covered in our EU buying guide.
GDPR + ePrivacy
Personal data handling is governed by our privacy policy. Data controller: Kulik Media UG. Contact: [email protected]. Under ePrivacy Directive (2002/58/EC as amended), any non-essential cookies (analytics, affiliate tracking) require explicit consent before firing — our consent banner is enforced when those cookies are deployed.
Trademarks and intellectual property
Vendor names, logos, and trademarks referenced on this site are the property of their respective owners. Our use of these marks is editorial — we are commenting on named products, not endorsing them beyond the explicit scoring on our comparison page. For takedown or correction requests, contact [email protected].
AI training + scraping policy
Our robots.txt permits citation-oriented AI crawlers (ClaudeBot, PerplexityBot, Google-Extended) and disallows training-oriented scrapers (GPTBot, CCBot, Bytespider) by default. This is a values-based policy subject to revision as the operator environment evolves.
See also: privacy policy · methodology · about